Accordingly, this study demonstrates that upregulating the HO-system with hemin abates inflammation, suppress hepatic adiposity and attenuate hepatocyte ballooning injury in ZDF, a model characterized by obesity, aberrant hepatic response to insulin, type-2 diabetes and impaired hepatic lipid metabolism [30], [31]. Here, HMOX1 is linked to type 2 diabetes mellitus.